TherapeuticsMD TXMD
NASDAQ TXMD
$2.06 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Short-term Investments (2022)

TherapeuticsMD's (TXMD) quarterly Short-term Investments came in at $11.2 million in Q4 2022, little changed on a QoQ basis from $11.2 million in Q3 2022.

TherapeuticsMD (TXMD) Short-term Investments (2022) Analysis & Trends

TherapeuticsMD (TXMD) has 1 years of Short-term Investments data on file, last reported at $11.2 million in Q4 2022.

  • Quarterly Short-term Investments changed N/A year-over-year to $11.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $11.2 million (changed N/A YoY) and the FY2022 annual result came in at $11.2 million, changed N/A from the prior year.
  • Short-term Investments held at $11.2 million in Q4 2022, from $11.2 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $11.2 million in Q2 2022 to a low of $11.2 million in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 TherapeuticsMD 23.78 Mn 14.60 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 11.25 Mn
Sep 30, 2022 11.25 Mn
Jun 30, 2022 11.25 Mn